It has also been shown that interventions to either buffer consequences of oxidative phosphorylation defects (e.g. redox imbalances) or reduce energetic demands (e.g. via mechanistic target of rapamycin (mTOR) inhibition) can delay brain disease and extend life in the mouse. Here, MTOR is linked to brain disorder.